Regulation of Fat Metabolism: Synthesis, NADPH Sources, and the Citrate Shuttle

Sources of NADPH for Fatty Acid Synthesis

• Requirement for NADPH in Synthesis: During the process of fatty acid synthesis mediated by the fatty acid synthase enzyme complex, NADPH is required as a reductant at specific points in the cyclic reaction sequence.

  • Reaction Steps: NADPH is consumed at step 2 and step 4 of each round of the fatty acid synthase reaction.

  • Stoichiometry: Every time a two-carbon unit is added to the growing fatty acid chain, $2$ molecules of NADPH are required.

• The Pentose Phosphate Pathway (PPP): This is the primary source of NADPH for biosynthetic reactions occurring in the cytosol.

  • Entry Point: The pathway branches off from glycolysis at the level of glucose-6-phosphate.

  • Products:

    • NADPH: Vital for cytosolic biosynthetic reactions, including fat synthesis.

    • Ribulose-5-Phosphate: This product is used in other biosynthetic pathways, most significantly for the synthesis of DNA and RNA.

• The Malic Enzyme Pathway: A second significant source of cytosolic NADPH through the oxidative decarboxylation of malate.

  • Reaction: Malic enzyme converts malate into pyruvate and carbon dioxide ($CO_2$).

  • Redox Component: During this conversion, $NADP^{+}$ is reduced to NADPH, and a proton ($H^{+}$) is released.

  • Availability: This specific pool of NADPH is then directly available for fatty acid synthesis within the cytosol.

The Acetyl-CoA Shuttle and Transport

• Localization Problem: Fatty acid synthesis occurs in the cytosol, but the substrates and production sites for acetyl-CoA are sequestered within the mitochondria.

  • Mitochondrial Sources of Acetyl-CoA:

    • The activity of the pyruvate dehydrogenase complex (converting pyruvate to acetyl-CoA).

    • Fatty acid degradation (beta-oxidation).

  • Membrane Barrier: Acetyl-CoA cannot pass directly through the inner mitochondrial membrane because there is no specific transporter available for it.

• The Citrate Shuttle Mechanism: To move the two-carbon units into the cytosol, the cell employs a metabolite shuttle system.

  1. Condensation: Within the mitochondrial matrix, acetyl-CoA and oxaloacetate condense to form citrate, catalyzed by the citric acid cycle enzyme citrate synthase.

  2. Transport: There is a specific transporter for citrate in the inner mitochondrial membrane, allowing citrate to move into the cytosol.

  3. Cleavage: In the cytosol, the enzyme citrate lyase breaks citrate back down into acetyl-CoA and oxaloacetate. This is an energy-requiring process.

• Recovery of Oxaloacetate: Once oxaloacetate is released in the cytosol, it must be returned to the mitochondria to maintain the balance of citric acid cycle intermediates.

  • Conversion to Malate: Cytosolic oxaloacetate is reduced to malate by the cytosolic isoform of malate dehydrogenase, utilizing NADH as the reductant.

  • Pathway A (Direct Return): Malate can be transported directly back across the inner mitochondrial membrane into the matrix, where the mitochondrial malate dehydrogenase converts it back to oxaloacetate.

  • Pathway B (Via Pyruvate and Malic Enzyme):

    • Cytosolic malate is converted to pyruvate by the malic enzyme, generating NADPH and releasing $CO_2$.

    • Pyruvate enters the mitochondria via the mitochondrial pyruvate transporter.

    • Inside the matrix, pyruvate carboxylase converts pyruvate back into oxaloacetate.

    • Anaplerosis: This pyruvate carboxylase step is considered an anaplerotic step, as it replenishes the oxaloacetate levels for the citric acid cycle.

• Synergy: The malic enzyme pathway is particularly efficient because it provides both the carbon (via the shuttle) and the reducing power (NADPH) necessary for fatty acid synthesis simultaneously.

Regulation of Fatty Acid Synthesis

• Acetyl-CoA Carboxylase (ACC): This enzyme catalyzes the conversion of acetyl-CoA to malonyl-CoA. It is the first committed step of fatty acid synthesis and serves as the primary regulatory point.

• Allosteric Regulation:

  • Citrate Activation: High levels of citrate indicate that the citric acid cycle is backed up (potentially due to high ATP/energy levels and negative feedback on oxidative phosphorylation). Citrate acts as an allosteric activator of ACC, signaling that the cell has sufficient energy to store carbon as fat.

  • Palmitoyl-CoA Inhibition: The final product of fatty acid synthesis, palmitoyl-CoA, acts as a feedback inhibitor on ACC. This prevents the overproduction of fatty acids when they are already abundant.

• Hormonal Regulation:

  • Insulin (High Blood Glucose):

    • Indicates an abundance of fuel.

    • Triggers the activation of citrate lyase, increasing acetyl-CoA availability in the cytosol.

    • Triggers a dephosphorylation cascade that removes a phosphate group from acetyl-CoA carboxylase, thereby activating it and switching on fatty acid synthesis.

  • Glucagon and Epinephrine (Low Blood Glucose/Stress):

    • Glucagon signals low glucose; Epinephrine (adrenaline) signals high energy demand.

    • These hormones trigger a phosphorylation cascade via protein kinase A (PKA).

    • PKA phosphorylates acetyl-CoA carboxylase, rendering the enzyme inactive and slowing down the fat synthesis pathway.

Prevention of Futile Cycles and Coordination

• The Futile Cycle Concept: If fatty acid synthesis and fatty acid breakdown (oxidation) were to occur simultaneously, the cell would waste significant energy without achieving a net metabolic goal.

• Compartmentalization: The physical separation of the two processes provides a fundamental level of regulation.

  • Synthesis: Occurs in the cytosol.

  • Degradation (Beta-Oxidation): Occurs in the mitochondrial matrix.

  • The mitochondrial membrane acts as a barrier separating the pools of acetyl-CoA.

• Malonyl-CoA as a Dual Regulator: Malonyl-CoA is not only the building block for synthesis but also a potent inhibitor of fatty acid breakdown.

  • Inhibition of CAT1: Malonyl-CoA inhibits the enzyme carnitine acyltransferase I (CAT1).

  • Mechanism: CAT1 is responsible for joining the activated fatty acyl-CoA to carnitine to allow transport into the mitochondria.

  • Effect: When malonyl-CoA levels are high (signaling active synthesis), fatty acids are barred from entering the mitochondria, effectively shutting down beta-oxidation.

• The Carnitine Shuttle for Oxidation:

  1. Fatty acids are activated to fatty acyl-CoA in the cytosol.

  2. CAT1 converts fatty acyl-CoA to fatty acyl-carnitine.

  3. Fatty acyl-carnitine is transported into the mitochondrial matrix.

  4. Carnitine acyltransferase II (CAT2) converts it back to fatty acyl-CoA in the matrix for beta-oxidation, releasing carnitine back to the cytosol.